Patents by Inventor Darryl Andrew Knight

Darryl Andrew Knight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent for emphysema and COPD
    Patent number: 9585930
    Abstract: The invention described herein relates to methods of treating emphysema and COPD with a GHK tripeptide. The invention further relates to methods of determining the state of the lungs using biomarkers described herein.
    Type: Grant
    Filed: March 20, 2012
    Date of Patent: March 7, 2017
    Assignees: Trustees of Boston University, The University of British Columbia
    Inventors: Avrum Spira, Marc Lenburg, Joshua Campbell, Dimitri Petchkovski, Darryl Andrew Knight, James Cameron Hogg, Julie Erin Zeskind Gil
  • THERAPEUTIC AGENT FOR EMPHYSEMA AND COPD
    Publication number: 20140199411
    Abstract: The invention described herein relates to methods of treating emphysema and COPD with a GHK tripeptide. The invention further relates to methods of determining the state of the lungs using biomarkers described herein.
    Type: Application
    Filed: March 20, 2012
    Publication date: July 17, 2014
    Applicants: THE UNIVERSITY OF BRITISH COLUMBIA, TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Avrum Spira, Marc Lenburg, Joshua Campbell, Dimitri Petchkovski, Darryl Andrew Knight, James Cameron Hogg, Julie Erin Zeskind Gil